Russia approved the coronavirus vaccine CoviVac, which is produced by the Chumakov Centre, making it the third COVID-19 vaccine authorised in the country, as reported in Financial Post.
CoviVac, which has not yet gone through large-scale studies, is a "whole-virion" vaccine given in two doses, 14 days apart,
According to virologist Alexander Chepurnov, as CoviVac includes all elements of the virus, it may create a broader immune response that is likely to protect against any variants.
Aidar Ishmukhametov, director of the Chumakov Centre, said CoviVac has been tested for safety on 200 people aged between 18 and 60, while mid-stage trials to test immune responses are ongoing.
To read more NewsPoints articles, click here.